Combining Ipilimumab with local treatments improved survival for patients with melanoma

(American Association for Cancer Research) Among patients with melanoma, those who received both ipilimumab (Yervoy) and local peripheral treatments such as radiotherapy or electrochemotherapy had significantly prolonged overall survival compared with those who received only ipilimumab, according to a retrospective clinical study.